Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model

Bioimpacts. 2019;9(1):65. doi: 10.15171/bi.2019.08. Epub 2019 Jan 12.

Authors

Ananda Mookerjee¹, Michele Graciotti², Lana E Kandalaft^{1

2}

Affiliations

¹ Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA.
² Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland.

Abstract

[This corrects the article DOI: 10.15171/bi.2018.24.].

Publication types

Published Erratum